Novo Nordisk (Exhibitor)

Back to conference portal

About Novo Nordisk

Novo Nordisk is a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases. We manufacture products for Diabetes such as GLP1 Receptor Agonists; Ozempic®(semaglutide injection), Rybelsus®(semaglutide tablets) and Tresiba® insulin. Our Canadian head office is located in Mississauga, Ontario.

Contact: Joann Melnyk
Sales Representative 3
Email: jnno@novonordisk.com
Phone: 306-221-9755

Website